Literature DB >> 30143376

Predicting lymph node metastasis for endoscopic resection of superficial esophageal squamous cell carcinoma.

Dae Won Ma1, Da Hyun Jung2, Jie-Hyun Kim1, Jae Jun Park1, Young Hoon Youn1, Hyojin Park1.   

Abstract

OBJECTIVE: The aims of this study were to identify risk factors for lymph node metastasis and develop a reliable risk stratification system.
METHODS: Between May 2001 and December 2015, 262 patients who underwent endoscopic resection or surgery for superficial esophageal squamous cell carcinoma were enrolled. We evaluated possible predictive factors for lymph node metastasis: age, gender, tumor length, tumor area, circumferential spread, tumor location, gross appearance, depth of invasion, tumor differentiation, and lymphovascular invasion.
RESULTS: The incidence of lymph node metastasis was 14.5% (38/262). In multivariate analysis, tumor size (>15 mm), depth of invasion (submucosal invasion), and lymphovascular invasion were significantly associated with lymph node metastasis. These factors were included in the risk stratification system and assigned scores; the total risk stratification system score was 0 to 6. The area under the receiver operating characteristic curve for predicting lymph node metastasis was 0.869 (95% confidence interval, 0.813-0.926). The high-risk group (risk stratification system score ≥3) exhibited a significantly higher risk of lymph node metastasis than the low-risk group (score <3) (26.5% vs 1.6%). There was no lymph node metastasis in patients with a risk stratification system of 0. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the risk stratification system were 94.7%, 55.4%, 26.5%, 98.4%, and 61.1%, respectively.
CONCLUSIONS: We developed a risk stratification system that should facilitate the identification of patients with a high or low risk of lymph node metastasis. This may aid the precise selection of patients who can undergo endoscopic resection.
Copyright © 2018 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  lymph node metastasis; risk stratification system; superficial esophageal squamous cell carcinoma

Mesh:

Year:  2018        PMID: 30143376     DOI: 10.1016/j.jtcvs.2018.07.034

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma.

Authors:  Christina Oetzmann von Sochaczewski; Thomas Haist; Michael Pauthner; Markus Mann; Susanne Braun; Christian Ell; Dietmar Lorenz
Journal:  World J Surg       Date:  2020-04       Impact factor: 3.352

2.  Near-infrared fluorescence imaging-guided lymphatic mapping in thoracic esophageal cancer surgery.

Authors:  Xiaojin Wang; Yi Hu; Xiangwen Wu; Mingzhu Liang; Zhenhua Hu; Xiangfeng Gan; Dan Li; Qingdong Cao; Hong Shan
Journal:  Surg Endosc       Date:  2021-09-07       Impact factor: 3.453

3.  Development and validation of a nomogram for preoperative prediction of lymph node metastasis in pathological T1 esophageal squamous cell carcinoma.

Authors:  Ling Chen; Kaiming Peng; Ziyan Han; Shaobin Yu; Zhixin Huang; Hui Xu; Mingqiang Kang
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

4.  Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Kai-Yuan Jiang; Heng Huang; Wei-Yang Chen; Hao-Ji Yan; Zhen-Ting Wei; Xiao-Wen Wang; Hao-Xuan Li; Xiang-Yun Zheng; Dong Tian
Journal:  World J Gastroenterol       Date:  2021-02-28       Impact factor: 5.742

5.  Prediction of Lymph Node Metastasis in Superficial Esophageal Cancer Using a Pattern Recognition Neural Network.

Authors:  Han Chen; Xiaoying Zhou; Xinyu Tang; Shuo Li; Guoxin Zhang
Journal:  Cancer Manag Res       Date:  2020-11-27       Impact factor: 3.989

6.  A Population-Based Study: How to Identify High-Risk T1-2 Esophageal Cancer Patients?

Authors:  Yiming Qi; Shuangshuang Wu; Linghui Tao; Guoshu Xu; Jiabin Chen; Zhengquan Feng; Chao Lu; Yanli Wan; Jing Li
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.